- InvestInvestment SuiteExclusiveFeatures
- PlatformProduct SuiteFeatures and ToolsCalculatorsPricing
- ResearchResearch CallsResearch Reports
- MarketStocksIndicesMutual FundsIPO
- LearnResourceInvesting GuideEvents
- Partner
- Support
Invest
Platform
Research
Market
Learn
Compare HDFC Pharma And Healthcare Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Fund Details
Risk | Very High | Very High |
Rating | 0.0 | 5.0 |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 2.17 | 1.92 |
NAV | ₹15.90 | ₹37.42 |
Fund Started | 14 Sep 2023 | 25 Jun 2018 |
Fund Size | ₹1382.60 Cr | ₹5024.00 Cr |
Exit Load | Exit load of 1%, if redeemed within 30 days. | Exit load of 1% if redeemed within 15 days. |
Risk
Very High
Very High
Rating
0.0
5.0
Min SIP Amount
₹100
₹100
Expense Ratio
2.17
1.92
NAV
₹15.90
₹37.42
Fund Started
14 Sep 2023
25 Jun 2018
Fund Size
₹1382.60 Cr
₹5024.00 Cr
Exit Load
Exit load of 1%, if redeemed within 30 days.
Exit load of 1% if redeemed within 15 days.
Returns
1 Year | 50.48% | 47.43% |
3 Year | - | 23.16% |
5 Year | - | 30.01% |
1 Year
50.48%
47.43%
3 Year
-
23.16%
5 Year
-
30.01%
Holding Analysis
Equity | 99.23% | 97.87% |
Cash | 0.77% | 2.13% |
Equity
99.23%
97.87%
Cash
0.77%
2.13%
Top Holdings
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 14.02% |
Cipla Ltd. | 8.17% |
Divi's Laboratories Ltd. | 7.91% |
Lupin Ltd. | 6.25% |
Ipca Laboratories Ltd. | 4.08% |
Gland Pharma Ltd. | 4.00% |
Aurobindo Pharma Ltd. | 3.44% |
Piramal Pharma Ltd. | 3.41% |
Dr. Reddy's Laboratories Ltd. | 3.32% |
Eris Lifesciences Ltd. | 3.27% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 14.35% |
Dr. Reddy's Laboratories Ltd. | 9.03% |
Cipla Ltd. | 8.07% |
Lupin Ltd. | 4.59% |
Aurobindo Pharma Ltd. | 4.57% |
Gland Pharma Ltd. | 4.22% |
Apollo Hospitals Enterprise Ltd. | 3.80% |
Zydus Lifesciences Ltd. | 2.93% |
Divi's Laboratories Ltd. | 2.69% |
Biocon Ltd. | 2.39% |
Fund Manager
Name | Dhruv Muchhal | Dharmesh Kakkad |
Start Date | 14 Sep 2023 | 23 Feb 2021 |
Name
Dhruv Muchhal
Dharmesh Kakkad
Start Date
14 Sep 2023
23 Feb 2021
About Fund
Description | The scheme seeks to provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies. | The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies. |
Launch Date | 14 Sep 2023 | 25 Jun 2018 |
Description
The scheme seeks to provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
14 Sep 2023
25 Jun 2018
